XML 47 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Current assets:        
Cash and cash equivalents $ 264 $ 327 $ 595 $ 512
Short-term investments 4 7    
Accounts receivable, net 977 951    
Inventories 861 824    
Prepaid expenses 54 29    
Total current assets 2,160 2,138    
Property, plant and equipment, net of accumulated depreciation of $3,056 and $2,915, respectively 2,306 2,198    
Goodwill 801 791 803  
Other intangible assets, net of accumulated amortization of $197 and $167, respectively 437 460    
Operating lease assets 151      
Deferred income tax assets 13 10    
Other assets 172 131    
Total assets 6,040 5,728    
Current liabilities:        
Short-term borrowings 82 169    
Accounts payable 504 452    
Accrued liabilities 381 325    
Total current liabilities 967 946    
Non-current liabilities 220 217    
Long-term debt 1,766 1,931    
Non-current operating lease liabilities 120      
Deferred income tax liabilities 195 189    
Share-based payments subject to redemption 31 37 $ 36 $ 30
Ingredion stockholders' equity:        
Preferred stock - authorized 25,000,000 shares - $0.01 par value, none issued    
Common stock - authorized 200,000,000 shares - $0.01 par value, 77,810,875 issued at December 31, 2019 and 2018, respectively 1 1    
Additional paid-in capital 1,137 1,096    
Less: Treasury stock (common stock: 10,993,388 and 11,284,681 shares at December 31, 2019 and 2018, respectively) at cost (1,040) (1,091)    
Accumulated other comprehensive loss (1,158) (1,154)    
Retained earnings 3,780 3,536    
Total Ingredion stockholders' equity 2,720 2,388    
Non-controlling interests 21 20    
Total equity 2,741 2,408    
Total liabilities and equity $ 6,040 $ 5,728